
Poly Medicure Limited Announces Q1 Financial Results, ESOP Allotment, and Governance Updates
Poly Medicure Limited held a Board of Directors meeting on August 7, 2026, during which it approved several significant corporate actions, including the unaudited financial results for the first quarter ended June 30, 2026. The meeting also covered the granting and allotment of stock options, the re-appointment of Cost Auditors, and the resignation of a Key Managerial Personnel (KMP).Financial Results Snapshot
The company released its consolidated and standalone unaudited financial results for the quarter ending June 30, 2026. The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors.Key performance indicators from the unaudited results are as follows:
| Particulars | Value (Standalone) | Value (Consolidated) |
|---|---|---|
| Total Income (A) | 45,974.91 | 55,878.45 |
| Total Expenses (B) | 34,110.97 | 44,303.21 |
| Profit Before Tax | 11,863.94 | 11,575.24 |
| Profit After Tax | 8,812.33 | 8,527.43 |
The unaudited results for the quarter ending March 31, 2026, have been prepared as balancing figures between the audited figures of the full financial year and published year to date figures.
Capital Structure and Employee Benefits
The company confirmed a capital structure adjustment following the allotment of stock options under its Employee Stock Option Scheme 2020. The Nomination & Remuneration Committee approved the allotment of 1,975 Equity Shares, each having a face value of Rs. 5, to eligible employees who exercised their options.Consequent to this transaction, the paid-up Equity Share Capital of Poly Medicure Limited increased from Rs 50,67,97,450 (consisting of 10,13,59,490 equity shares) to Rs 50,68,07,325 (consisting of 10,13,61,465 equity shares).
In related news concerning employee motivation, the Committee also approved the grant of 1,476 Stock Options under the Employee Stock Option Scheme 2020 to eligible employees. The options were granted at an exercise price of Rs 100/- per share.
Governance and Appointments
The Board meeting addressed critical matters related to corporate governance:Cost Audit Appointment:
M/s Jai Prakash & Company was re-appointed as the Cost Auditors of Poly Medicure Limited for the Financial Year 2026-27. M/s Jai Prakash & Co, established in 2006, is a firm specializing in cost accounting and has experience serving various industries including pharmaceuticals and engineering.
KMP Resignation:
The Board noted the resignation of Mr Ravi Prakash from his position as Deputy Company Secretary and Compliance Officer (Key Managerial Personnel). He tendered his resignation on July 21, 2026, stating a desire to pursue alternative career opportunities outside the organization. Mr Prakash is scheduled to be relieved of his responsibilities effective August 10, 2026.
Consolidated Group Entities
The consolidated financial statements for the quarter ending June 30, 2026, include the company and various subsidiaries and associates across different countries:| Sr. No. | Name of the Company | Country of Incorporation | Holding as on June 30, 2026 |
|---|---|---|---|
| Parent Company | Poly Medicure Limited | - | - |
| Subsidiary 1 | Plan 1 Health India Private Limited | India | 100% |
| Subsidiary 2 | Poly Medicure (Laiyang) Company Limited | China | 100% |
| Subsidiary 3 | Poly Medicure B.V. | Netherlands | 100% |
| Subsidiary 4 | Polymed Brazil LTDA | Brazil | 100% |
| Subsidiary 5 | Himalayan Mineral Waters Private Limited | India | - |
| Subsidiary 6 | Plan I Health SRL | Italy | 100% |
| Subsidiary 7 | Risor Holding B.V. | Netherlands | 90% |
| Subsidiary 8 | Wellino Medical B.V. | Netherlands | 100% |
| Subsidiary 9 | Pendracare Holding B.V. | Netherlands | 100% |
| Subsidiary 10 | Pendracare Vascular B.V. | Netherlands | 100% |
| Subsidiary 11 | Pendracare International B.V. | Netherlands | 100% |
| Subsidiary 12 | Medi stream SA | Switzerland | 100% |
| Subsidiary 13 | Citieffe SRL | Italy | 100% |
| Subsidiary 14 | Citieffe Inc. | USA | 100% |
| Subsidiary 15 | Citieffe De. | Mexico | 100% |
| Subsidiary 16 | Poly Health Inc. | USA | 100% |
| Subsidiary 17 | Poly Health Limited | UK | 100% |
| Associate | Medyneo Comercio De Produtos Para Saude LTDA | Brazil | 100% |
| Associate | Ultra For Medical Products Company (Ultra Med) | Egypt | 23% |
POLYMED Stock Price Movement
Today, Poly Medicure Limited shares shed 0.82% in post-market trading, closing at ₹1695.20. The stock traded a volume of 225,164 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.